diaRNAgnosis – New platform for an accurate diagnosis and staging of cancer with ‘liquid biopsy’

The company is pleased to announce the commencing of a new collaborative European project “diaRNAgnosis”. In the framework of the project, NanoGetic SL will join forces with the other Spanish company DESTINA Genomica SL and the Italian OPTOI Srl to develop reliable, innovative method and platform to identify cancer biomarkers in liquid biopsies. In this [...]